LEUTZINGER KURT 4
4 · Pharmasset Inc · Filed Oct 13, 2011
Insider Transaction Report
Form 4
Pharmasset IncVRUS
LEUTZINGER KURT
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-10-11+75,000→ 75,000 totalExercise: $83.52Exp: 2021-10-10→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Shares vest on the following schedule: 25% on the first anniversary of the grant and 6.25% quarterly thereafter.